Doctors in Star Trek: Dr. Phlox in Star Trek: Enterprise.


Journal

Early human development
ISSN: 1872-6232
Titre abrégé: Early Hum Dev
Pays: Ireland
ID NLM: 7708381

Informations de publication

Date de publication:
05 2020
Historique:
pubmed: 29 2 2020
medline: 27 8 2021
entrez: 29 2 2020
Statut: ppublish

Résumé

Since Dr. McCoy in The Original Series, Star Trek has had a doctor in every subsequent series. Star Trek: Enterprise ran between 2001 and 2005. In this series, the alien humanoid Doctor Phlox was the chief medical officer of the starship Enterprise NX-01. Phlox is truly alien, both biologically and in his cultural norms. However he is tolerant of human mores and customs and indeed, embraces them. His very alienness occasionally saves the crew from attacks which exploit human vulnerabilities. It is also this alienness, with very little sleep requirements, that permits him to be almost always available to his patients. Furthermore, Phlox frequently used an array of exotic alien flora and fauna in his medical treatments, but he does not eschew modern medicine, professionally utilising the typical gamut of futuristic instruments and devices to which Star Trek audiences are accustomed. He is thus the "the prototype of the multicultural homeopathic physician of the future, comfortable with technology but knowledgeable regarding the more natural means of healing". It is these two traits which endear him to modern viewers, availability and naturalistic treatments. He is a truly unique doctor who furthers the vision of Star Trek's creator, Gene Roddenberry, of a multicultural bridge crew, since the inception of The Original Series in 1966.

Identifiants

pubmed: 32107113
pii: S0378-3782(20)30098-0
doi: 10.1016/j.earlhumdev.2020.104994
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104994

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest There are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.

Auteurs

Victor Grech (V)

Paediatric Department, Mater Dei Hospital, Malta. Electronic address: victor.e.grech@gov.mt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH